Deutsche Bank Ag\ Nymox Pharmaceutical Corp Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$1.46 - $2.48 $44,246 - $75,158	-30,306 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$2.22 - $3.39 $5,700 - $8,705	-2,568 Reduced 7.81%	30,306 $67,000
Q4 2020 Feb 16, 2021	BUY	$1.84 - $2.83 $17,779 - $27,346	9,663 Added 41.63%	32,874 $82,000
Q3 2020 Nov 12, 2020	BUY	$2.3 - $3.66 $4,356 - $6,932	1,894 Added 8.88%	23,211 $57,000
Q2 2020 Aug 13, 2020	SELL	$2.1 - $4.6 $18,234 - $39,941	-8,683 Reduced 28.94%	21,317 $76,000
Q1 2020 May 14, 2020	BUY	$1.69 - $3.88 $27,268 - $62,603	16,135 Added 116.37%	30,000 $70,000
Q4 2019 Feb 14, 2020	BUY	$1.73 - $2.42 $10,447 - $14,614	6,039 Added 77.17%	13,865 $30,000
Q3 2019 Nov 14, 2019	SELL	$1.41 - $2.12 $20,676 - $31,087	-14,664 Reduced 65.2%	7,826 $14,000
Q2 2019 Aug 14, 2019	SELL	$1.33 - $2.12 $22,381 - $35,675	-16,828 Reduced 42.8%	22,490 $31,000
Q1 2019 May 15, 2019	SELL	$1.57 - $2.71 $3,837 - $6,623	-2,444 Reduced 5.85%	39,318 $76,000
Q4 2018 Feb 14, 2019	SELL	$1.31 - $2.53 $41,094 - $79,366	-31,370 Reduced 42.9%	41,762 $53,000
Q3 2018 Dec 21, 2021	BUY	$2.46 - $3.7 $21,082 - $31,709	8,570 Added 13.27%	73,132 $180,000
Q3 2018 Nov 14, 2018	BUY	$2.46 - $3.7 $9,126 - $13,727	3,710 Added 6.1%	64,562 $157,000
Q2 2018 Apr 21, 2020	BUY	$3.12 - $4.33 $31,368 - $43,533	10,054 Added 19.79%	60,852 $205,000
Q2 2018 Aug 14, 2018	BUY	$3.12 - $4.33 $28,048 - $38,926	8,990 Added 21.5%	50,798 $169,000
Q1 2018 Oct 18, 2019	BUY	$3.09 - $4.43 $21,422 - $30,713	6,933 Added 19.88%	41,808 $176,000
Q1 2018 May 15, 2018	SELL	$3.09 - $4.43 $113,161 - $162,235	-36,622 Reduced 51.22%	34,875 $147,000
Q4 2017 Feb 14, 2018	BUY	$3.29 - $4.06 $143,684 - $177,312	43,673 Added 156.96%	71,497 $234,000
Q3 2017 Nov 14, 2017	BUY	$3.36 - $4.02 $93,488 - $111,852	27,824	27,824 $105,000

Others Institutions Holding NYMX

# of Institutions

Shares Held

150K

Call Options Held

Put Options Held

View Full List

About NYMOX PHARMACEUTICAL CORP

Ticker NYMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,265,000
Market Cap $42.9M
Description
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...

More about NYMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account